ProtoKinetix CEO and Scientific Advisory Board to Meet in Paris to Discuss Preliminary Results of Third Party RECAF Validation Studies
April 15, 2004 12:10 ET
|
ProtoKinetix, Incorporated
VANCOUVER, British Columbia, April 15, 2004 (PRIMEZONE) -- ProtoKinetix Inc. (OTCBB:PKTX), announces today that it has received a preliminary report from their new Director of Medical Research in...
Dr. Jean-Marie Dupuy Accepts Position on ProtoKinetix Board of Directors
April 07, 2004 09:15 ET
|
ProtoKinetix, Incorporated
VANCOUVER, British Columbia, April 7, 2004 (PRIMEZONE) -- Dr. John Todd, president of ProtoKinetix, Inc. (OTCBB:PKTX), is pleased to announce that Dr. Jean-Marie Dupuy has accepted a position on the...
ProtoKinetix Awarded License by University of Michigan
February 03, 2004 10:17 ET
|
ProtoKinetix, Incorporated
VANCOUVER, British Columbia, Feb. 3, 2004 (PRIMEZONE) -- ProtoKinetix Inc. (OTCBB:PKTX) is excited to announce that it has entered into an exclusive agreement with the University of Michigan under...
University of Michigan Grants License to ProtoKinetix
February 02, 2004 13:00 ET
|
ProtoKinetix, Incorporated
VANCOUVER, British Columbia, Canada, Feb. 2, 2004 (PRIMEZONE) -- ProtoKinetix Inc. (OTCBB:PKTX) is excited to announce that it has entered into an exclusive agreement with the University of Michigan...
ProtoKinetix Completes Agreement with Perigene, Inc.
December 29, 2003 11:03 ET
|
ProtoKinetix, Incorporated
VANCOUVER, B.C., Dec. 29, 2003 (PRIMEZONE) -- ProtoKinetix, Inc. has (OTCBB:PKTX) today satisfied the research agreement with Perigene pursuant to the Company's December 11, 2003 News Release. This...
Dr. Jean-Marie Dupuy Accepts Position on ProtoKinetix Scientific Advisory Board
November 12, 2003 08:00 ET
|
ProtoKinetix, Incorporated
VANCOUVER, British Columbia, Canada, Nov. 12, 2003 (PRIMEZONE) -- ProtoKinetix Inc. (OTCBB:PKTX) -- In conjunction with PKTX recent collaboration announcements, Dr. Jean-Marie Dupuy has honored the...
ProtoKinetix, Inc. -- Dr. John Todd States How Validation Trials Will Fast Track Therapeutic Development
October 29, 2003 08:00 ET
|
ProtoKinetix, Incorporated
VANCOUVER, British Columbia, Canada, Oct. 29, 2003 (PRIMEZONE) -- As a follow-up to last week's announcement of validation trials, Dr. John Todd, president of ProtoKinetix (OTCBB:PKTX), states how...
ProtoKinetix Announces Independent Group of Validation Trials by European Hospital Georges Pompidou
October 23, 2003 10:23 ET
|
ProtoKinetix, Incorporated
Vancouver, British Columbia, Canada, Oct. 23, 2003 (PRIMEZONE) -- We are pleased to announce that ProtoKinetix (OTCBB:PKTX) has arranged (through *Dr. Jean-Marie Dupuy) an extensive independent...
ProtoKinetix Completes Licensing Agreement
September 30, 2003 09:27 ET
|
ProtoKinetix, Incorporated
VANCOUVER, B.C., Sept. 30, 2003 (PRIMEZONE) -- ProtoKinetix, Inc. (OTCBB:PKTX), formally RJV Networks, Inc., announces that it has completed the global licensing assignment agreement with BioKinetix...
ProtoKinetix Announces Appointment of Dr. Ricardo Moro-Vidal to it's Scientific Advisory Board
September 22, 2003 11:17 ET
|
ProtoKinetix, Incorporated
VANCOUVER, British Columbia, Canada, Sept. 22, 2003 (PRIMEZONE) -- ProtoKinetix, Inc. is pleased to announce the appointment of Dr. Ricardo Moro-Vidal to its Scientific Advisory Board. Dr. Moro...